Effect of age on interdependence and hierarchy of cardiovascular risk factors in hypertensive patients

Gregory Vyssoulis1, Evangelia Karpanou, Dionysios Adamopoulos

  • 1Hypertension Unit, First Cardiology Department, "Hippokration" Hospital, Athens, Greece.

Insights

Cardiovascular risk factors like blood pressure and dyslipidemia become less linked to obesity in older adults. Low-grade inflammation increasingly drives these risks, independent of central obesity, in elderly hypertensive patients.

Area of Science:

  • Cardiology
  • Gerontology
  • Metabolic Syndrome Research

Background:

  • Cardiovascular risk factors' prognostic significance can change with age.
  • Understanding age-related shifts in risk factor interdependence is crucial for hypertension management.

Purpose of the Study:

  • To investigate how the interdependence of blood pressure, metabolic syndrome components, and C-reactive protein varies with age in hypertensive patients.
  • To determine if central obesity remains a primary driver of cardiovascular risk in older hypertensive individuals.

Main Methods:

  • Analysis of 5,712 non-diabetic hypertensive patients aged 40-95, stratified into five age groups.
  • Evaluation of office and 24-hour ambulatory blood pressure monitoring (BP), metabolic syndrome components, and high-sensitivity C-reactive protein (hs-CRP) after drug washout.
  • Statistical analysis of associations between variables across different age strata.

Main Results:

  • Metabolic syndrome prevalence was stable across age groups.
  • Associations between waist circumference and systolic BP, HDL cholesterol, and triglycerides decreased with age.
  • High-sensitivity C-reactive protein became a stronger determinant of systolic BP and HDL cholesterol in patients over 80, independent of waist circumference.

Conclusions:

  • Hypertension and dyslipidemia dissociate from central obesity in older hypertensive individuals.
  • Low-grade inflammation, indicated by hs-CRP, increasingly influences cardiovascular risk factors in the elderly, irrespective of central obesity.
  • These age-related changes may explain the diminished role of obesity as a cardiovascular risk factor in older populations.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...